146 related articles for article (PubMed ID: 20728838)
1. Reduction of cutaneous photosensitivity by application of ointment containing ferrous or cobaltous ions concomitant with the use of topical protoporphyrin IX precursors.
Juzenas P; Juzeniene A
Photodiagnosis Photodyn Ther; 2010 Sep; 7(3):152-7. PubMed ID: 20728838
[TBL] [Abstract][Full Text] [Related]
2. Clearance mechanism of protoporphyrin IX from mouse skin after application of 5-aminolevulinic acid.
Juzeniene A; Iani V; Moan J
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):538-45. PubMed ID: 24284108
[TBL] [Abstract][Full Text] [Related]
3. Topical aminolaevulinic acid- and aminolaevulinic acid methyl ester-based photodynamic therapy with red and violet light: influence of wavelength on pain and erythema.
Mikolajewska P; Iani V; Juzeniene A; Moan J
Br J Dermatol; 2009 Nov; 161(5):1173-9. PubMed ID: 19785604
[TBL] [Abstract][Full Text] [Related]
4. Protoporphyrin IX fluorescence kinetics in UV-induced tumours and normal skin of hairless mice after topical application of 5-aminolevulinic acid methyl ester.
Juzenas P; Sharfaei S; Moan J; Bissonnette R
J Photochem Photobiol B; 2002 May; 67(1):11-7. PubMed ID: 12007462
[TBL] [Abstract][Full Text] [Related]
5. Microscopic localisation of protoporphyrin IX in normal mouse skin after topical application of 5-aminolevulinic acid or methyl 5-aminolevulinate.
de Bruijn HS; Meijers C; van der Ploeg-van den Heuvel A; Sterenborg HJ; Robinson DJ
J Photochem Photobiol B; 2008 Aug; 92(2):91-7. PubMed ID: 18571933
[TBL] [Abstract][Full Text] [Related]
6. Topical application of 5-aminolevulinic acid and its methylester, hexylester and octylester derivatives: considerations for dosimetry in mouse skin model.
Juzeniene A; Juzenas P; Iani V; Moan J
Photochem Photobiol; 2002 Sep; 76(3):329-34. PubMed ID: 12403455
[TBL] [Abstract][Full Text] [Related]
7. Protoporphyrin IX fluorescence kinetics and localization after topical application of ALA pentyl ester and ALA on hairless mouse skin with UVB-induced early skin cancer.
van den Akker JT; de Bruijn HS; Beijersbergen van Henegouwen GM; Star WM; Sterenborg HJ
Photochem Photobiol; 2000 Sep; 72(3):399-406. PubMed ID: 10989612
[TBL] [Abstract][Full Text] [Related]
8. Selectivity of protoporphyrin IX fluorescence for condylomata after topical application of 5-aminolaevulinic acid: implications for photodynamic treatment.
Ross EV; Romero R; Kollias N; Crum C; Anderson RR
Br J Dermatol; 1997 Nov; 137(5):736-42. PubMed ID: 9415233
[TBL] [Abstract][Full Text] [Related]
9. Light protection of the skin after photodynamic therapy reduces inflammation: an unblinded randomized controlled study.
Petersen B; Wiegell SR; Wulf HC
Br J Dermatol; 2014 Jul; 171(1):175-8. PubMed ID: 24506809
[TBL] [Abstract][Full Text] [Related]
10. In vitro percutaneous absorption and in vivo protoporphyrin IX accumulation in skin and tumors after topical 5-aminolevulinic acid application with enhancement using an erbium:YAG laser.
Shen SC; Lee WR; Fang YP; Hu CH; Fang JY
J Pharm Sci; 2006 Apr; 95(4):929-38. PubMed ID: 16493590
[TBL] [Abstract][Full Text] [Related]
11. Pain associated with photodynamic therapy using 5-aminolevulinic acid or 5-aminolevulinic acid methylester on tape-stripped normal skin.
Wiegell SR; Stender IM; Na R; Wulf HC
Arch Dermatol; 2003 Sep; 139(9):1173-7. PubMed ID: 12975159
[TBL] [Abstract][Full Text] [Related]
12. Systemic component of protoporphyrin IX production in nude mouse skin upon topical application of aminolevulinic acid depends on the application conditions.
van den Akker JT; Iani V; Star WM; Sterenborg HJ; Moan J
Photochem Photobiol; 2002 Feb; 75(2):172-7. PubMed ID: 11885562
[TBL] [Abstract][Full Text] [Related]
13. Topical photodynamic therapy using different porphyrin precursors leads to differences in vascular photosensitization and vascular damage in normal mouse skin.
Middelburg TA; de Vijlder HC; de Bruijn HS; van der Ploeg-van den Heuvel A; Neumann HA; de Haas ER; Robinson DJ
Photochem Photobiol; 2014; 90(4):896-902. PubMed ID: 24628584
[TBL] [Abstract][Full Text] [Related]
14. Protoporphyrin IX formation after topical application of methyl aminolaevulinate and BF-200 aminolaevulinic acid declines with age.
Nissen CV; Philipsen PA; Wulf HC
Br J Dermatol; 2015 Sep; 173(3):760-6. PubMed ID: 25997508
[TBL] [Abstract][Full Text] [Related]
15. Comparison of ALA- and ALA hexyl-ester-induced PpIX depth distribution in human skin carcinoma.
Dögnitz N; Salomon D; Zellweger M; Ballini JP; Gabrecht T; Lange N; van den Bergh H; Wagnières G
J Photochem Photobiol B; 2008 Dec; 93(3):140-8. PubMed ID: 18818091
[TBL] [Abstract][Full Text] [Related]
16. In vitro/in vivo correlations between transdermal delivery of 5-aminolaevulinic acid and cutaneous protoporphyrin IX accumulation and effect of formulation.
Tsai JC; Chen IH; Wong TW; Lo YL
Br J Dermatol; 2002 May; 146(5):853-62. PubMed ID: 12000384
[TBL] [Abstract][Full Text] [Related]
17. Oral aminolevulinic acid induces protoporphyrin IX fluorescence in psoriatic plaques and peripheral blood cells.
Bissonnette R; Zeng H; McLean DI; Korbelik M; Lui H
Photochem Photobiol; 2001 Aug; 74(2):339-45. PubMed ID: 11547574
[TBL] [Abstract][Full Text] [Related]
18. Optimization and therapeutic effects of PDT mediated by ALA and MAL in the treatment of cutaneous malignant lesions: A comparative study.
Lima CA; Goulart VP; Bechara EJ; Correa L; Zezell DM
J Biophotonics; 2016 Dec; 9(11-12):1355-1361. PubMed ID: 27653310
[TBL] [Abstract][Full Text] [Related]
19. Lack of selectivity of protoporphyrin IX fluorescence for basal cell carcinoma after topical application of 5-aminolevulinic acid: implications for photodynamic treatment.
Martin A; Tope WD; Grevelink JM; Starr JC; Fewkes JL; Flotte TJ; Deutsch TF; Anderson RR
Arch Dermatol Res; 1995; 287(7):665-74. PubMed ID: 8534131
[TBL] [Abstract][Full Text] [Related]
20. An investigation of the fluorescence induced by topical application of 5-aminolaevulinic acid and methyl aminolaevulinate at different body sites on normal human skin.
Lesar A; Ferguson J; Moseley H
Photodiagnosis Photodyn Ther; 2011 Jun; 8(2):97-103. PubMed ID: 21497300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
